The census arithmetic reproduces exactly, but **“ABSENT” overstates what the metadata establish**. The precommitted primary-key result remains zero; the broader repeat-resource conclusion fails because that key tracks ScreenID almost perfectly, while the condition-based key identifies a credible repeat candidate.

Read-only review completed without opening outcome files. Passports analysis used identifier columns only. I could not verify the requested runtime model/reasoning setting.

1. **HIGH — Primary-key absence is largely an identifier result.** After removing pDNA controls, there are **1,588 primary groups and 1,588 ScreenIDs, in one-to-one correspondence**. ModelConditionID is not universally screen-scoped—it spans two ScreenIDs in 27 eligible cases—but adding Library makes the primary key effectively screen-specific in this release. Zero therefore provides weak evidence about biological repeat availability. [Primary-key implementation](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen017_census.py:44)

   The counterexample is **ACH-000614**:

   - `SC-000614.AV01`: `MC-000614-7X1Q`, Avana, day 21, batch Avana-3, replicates A/B.
   - `SC-002875.AV01`: `MC-002875-AKge`, Avana, day 21, batch Avana-4, replicates A/B.
   - **Every ModelCondition field except ModelConditionID is identical**, including ModelID, format, formulation and coating.
   - All four sequences have explicit qualifying Boolean values, so this finding survives strict eligibility parsing.

   This is a credible same-recorded-condition repeat candidate. Sequence names suggest passages p5 versus p6, while structured PassageNumber is blank; complete biological equivalence remains unverified. [First screen](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ScreenSequenceMap.csv:881), [second screen](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ScreenSequenceMap.csv:2249), [condition record](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ModelCondition.csv:992)

2. **HIGH — Distinct ScreenID does not establish independent execution.** The SPEC defines independence operationally without validating experimental provenance. Five eligible biological ScreenIDs contain multiple pDNABatches. For example, `SC-000552.KY01` combines `HT29_c904R1–R3_KY-2` and `HT29_c905R1–R3_KY-1`, relabelled A–F. This suggests that potentially separate experimental units can be consolidated under one ScreenID. Four other ScreenIDs combine Avana-3/Avana-4 or other batch pairs. Conversely, separate IDs alone cannot exclude shared biological provenance.

   pDNABatch identifies input-reference batches, and Replicate labels do not resolve execution independence. Report **distinct annotated screens**, with independence unverified. The ACH-000614 pair has stronger supporting evidence from different batches and source names, but metadata still cannot prove independent initiation. [Definition](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen017/SPEC.md:17), [HT29 evidence](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ScreenSequenceMap.csv:3041)

3. **MEDIUM — Missing eligibility flags are silently interpreted as false.** Actual raw value sets are:

   | Field | `True` | `False` | Empty |
   |---|---:|---:|---:|
   | PassesQC | 3,478 | 145 | 0 |
   | DrugTreated | 14 | 3,203 | 406 |
   | IsEngineered | 34 | 3,183 | 406 |
   | ExcludeFromCRISPRCombined | 14 | 3,609 | 0 |

   Parsing observed `True`/`False` strings works. The problem is `not truthy("")`: **392 eligible sequences have both treatment and engineering flags missing**, rather than explicitly false. That is 11.42% of the eligible set.

   Requiring explicit false values yields **3,042 sequences, 1,367 primary groups, zero primary repeats, and one robustness repeat among 1,033 qualified groups**. The central candidate survives. Missing states should be reported separately and their eligibility justified. [Parser and filter](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen017_census.py:12)

4. **MEDIUM — pDNA controls are counted as eligible biological screens.** Ten eligible rows have `ScreenType=ModelID=ModelConditionID=ScreenID=pDNA`, day zero and blank Replicate. They create **five artificial primary groups**, one per library, despite representing one placeholder ScreenID.

   Removing them changes eligibility to **3,424 sequences / 1,588 screens**, primary groups to **1,588**, and robustness-unqualified sequences to **921**; repeat counts remain unchanged. [Example controls](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ScreenSequenceMap.csv:2279)

   **ScreenType reporting itself complies with the SPEC**: it required a distribution, not a CRISPR-only whitelist. Every current eligible row has a recorded ScreenType. No additional non-CRISPR screen inclusion is demonstrated by the permitted metadata; the clear erroneous inclusion is pDNA input controls.

5. **MEDIUM — Robustness missingness materially limits the headline.** The reported **931/3,434 unqualified sequences = 27.11%** comprise:

   - 227 missing both format and formulation;
   - 694 missing formulation only;
   - 10 pDNA rows without a condition join.

   They represent **338 distinct ScreenIDs**, including the pDNA placeholder. After removing controls, **921/3,424 sequences and 337 biological ScreenIDs** remain unqualified. Reporting sequences alone obscures the missingness in screen units; the SPEC describes unqualified groups, while the implementation counts rows. [Qualification logic](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen017_census.py:25)

   The honest headline is: **one candidate repeat among 1,266 qualified condition–library–day groups (0.079%); roughly 27% of eligible sequences cannot be assessed with that key; independence remains unverified.**

6. **MEDIUM — The robustness key is useful but incomplete.** Six qualified sequences have literal `CellFormat="unknown"`, because qualification checks only nonempty strings. Unknown format should remain unqualified. The key also omits potentially distinguishing metadata such as coating, passage and prescreen treatment. These omissions do **not** explain away ACH-000614: its complete condition records match except for their IDs. They limit the general equivalence claim. [Robustness key](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen017_census.py:46), [accepted unknown format](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ModelCondition.csv:1482)

7. **MEDIUM — Primary and robustness coverage use different observational units.** Primary omits Days; robustness includes it. Fourteen eligible ScreenIDs span multiple days, so the robustness denominator contains **1,267 screen memberships from 1,251 distinct qualified screens**, distributed across 1,266 groups. These are condition–day groups rather than interchangeable estimates of the same denominator. This difference needs explicit interpretation.

8. **LOW — The 27-versus-zero discrepancy is explained correctly by Library, with an additional duration difference.** All **27 eligible two-screen ModelConditionIDs pair Avana with Humagne-CD**. Splitting by Library therefore eliminates all 27 primary repeats. All 27 also pair **day 21 with day 14**, respectively. Library is defensible for measuring repeatability of the same assay design; its inclusion narrows the resource claim and excludes cross-library replication opportunities. The discrepancy is not a counting bug. [Example pair](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/ScreenSequenceMap.csv:37)

9. **LOW — Patient mapping is correct, but the reported path is vacuous.** BROAD_ID is the correct join: all 1,770 populated values are unique ACH identifiers; Passports `model_id` uses SIDM identifiers. Of 1,346 eligible biological ModelIDs, 1,080 match BROAD_ID and all have patient IDs.

   However, `models_repeat` is empty because it derives exclusively from primary repeats. The reported zeros therefore validate no nonempty end-to-end clustering case and omit the robustness candidate, which maps to **SIDP01038**. Describe this as an **unexercised nonempty path**, rather than evidence that repeat patients are absent. [Mapping implementation](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen017_census.py:55)

10. **LOW — Organoid detection does not match observed metadata vocabulary.** The code searches CellFormat for `"organoid"` or `"3d"`, but observed formats include **`dome` and `spheroid`**, neither matched. The 143 eligible `3DO` sequences map to `dome`; 48 `3DN` sequences map to `spheroid`. Neither should be classified through an undocumented substring heuristic. Current primary-repeat zero remains numerically correct, so this is a latent classification defect. [Classifier](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen017_census.py:59)

11. **LOW — Output and validation gaps weaken “CENSUS_COMPLETE.”** The JSON omits the explicitly requested distinct eligible-screen count. Breakdown and patient outputs cover only primary repeats, leaving the nonzero robustness result unexplained. There are no input fingerprints or assertions for identifier integrity, joins or valid Boolean states. Current checks found unique SequenceIDs, unique ModelConditionIDs and no biological ModelID join mismatches; those particular defects are absent. Twenty-six eligible screens contain both passing and failing sequences, which is consistent with sequence-level eligibility but deserves a screen-level QC summary.

12. **MEDIUM — Verdict bands are acceptable only as narrowly labelled descriptive bins.** The SPEC appropriately disclaims instability, persistence, direction, mechanism and statistical power. The thresholds are explicitly descriptive. However, `REPEAT_RESOURCE=ABSENT` conveys more than “zero exact primary-key repeats,” especially alongside a nonzero robustness census and unresolved independence. `CENSUS_COMPLETE` establishes execution of the algorithm, not construct validity. Prefer separate key-specific labels and an explicit provenance limitation. [Bands and non-claims](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen017/SPEC.md:31)

**No critical issue identified.** The numerical results are reproducible, but the independence definition and primary-key interpretation prevent approval at the SPEC’s ≥90 threshold. The exact locked primary label remains mechanically correct; the scientific interpretation of repeat-resource absence is overturned.

SGEN017_VERDICT: ABSENT_OVERTURNED
SGEN017_SCORE: 68